Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-01
2008-12-02
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S303000, C546S119000, C546S120000, C544S127000
Reexamination Certificate
active
07459451
ABSTRACT:
The invention relates to compound of the formula (I) or its salt, in which R1, R2, R3and R4are as defined in the description, their use of as medicament, the process for their preparation and use for the treatment of PDE-IV or TNF-α mediated diseases.
REFERENCES:
patent: 5024999 (1991-06-01), Fujikawa et al.
patent: 2005/0075342 (2005-04-01), Abe et al.
Mainou-Fowler et al., Leukemia and Lymphoma, 2000, vol. 38, p. 547-552.
U.S. Appl. No. 11/171,320, filed Jul. 1, 2005, Abe et al.
Abe Yoshito
Inoue Makoto
Ohne Kazuhiko
Okumura Mitsuaki
Sato Kentaro
Astellas Pharma Inc.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Pyrazolopyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030116